Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Effect of estrogen and selective estrogen receptor modulators on a mouse model of fallopian tube epithelia, an ovarian cancer precursor


ABSTRACT: The fallopian tube epithelium is one of the potential sources of high-grade serous ovarian cancer (HGSC). The use of estrogen only hormone replacement therapy increases ovarian cancer risk. Despite estrogenâ??s influence in OVCA, selective estrogen receptor modulators (SERMs) typically demonstrate only a 20% response rate. This low response could be due to a variety of factors including the loss of estrogen receptor signaling or the role of estrogen receptor signaling in different potential cell types of origin. The response of fallopian tube epithelium to SERMs is not known, and would be useful when determining therapeutic options for tumors that arise from this cell type, such as high-grade serous cancer. Using normal murine derived oviductal epithelial cells (mouse equivalent to the fallopian tube) estrogen receptor expression was confirmed and interaction with its ligand, estradiol, triggered mRNA and protein induction of progesterone receptor (PR). The SERMs 4-hydroxytamoxifen, raloxifene and desmethylarzoxifene, functioned as estrogen receptor antagonists in the oviductal cells. Cellular proliferation and migration assays suggested that estradiol does not significantly impact cellular migration and increased proliferation in CD1, but not in FVB derived cell lines. Further, using RNAseq, the oviduct specific transcriptional genes targets of estrogen and 4-hydroxytamoxifen signaling were determined and validated. The RNA-seq revealed enrichment in proliferation, anti-apoptosis, calcium signaling and steroid signaling processes. Finally, the ER and PR receptor status of a panel of HGSC cell lines was investigated highlighting the need for better models of estrogen responsive HGSC cell lines. Murine oviductal epithelial cells from the FVB background were hormone starved for 48 hours (with a media change after 24 hours), then treated in triplicate with solvent control (DMSO) (0.1%), 1 nM 17-betaestradiol or 100 nM 4-hydroxytamoxifen for 24 hours. Following treatment, RNA was was isolated, libraries were prepped and sequenced using the Illumina HiSeq 2500 platform.

ORGANISM(S): Mus musculus

SUBMITTER: Joanna Burdette 

PROVIDER: E-GEOD-67207 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2016-02-08 | GSE67207 | GEO
2014-10-25 | E-GEOD-62694 | biostudies-arrayexpress
2014-10-25 | GSE62694 | GEO
2013-12-17 | E-GEOD-49827 | biostudies-arrayexpress
2014-04-11 | E-GEOD-52011 | biostudies-arrayexpress
2019-12-10 | GSE137196 | GEO
2020-11-17 | GSE158886 | GEO
2020-11-17 | GSE158476 | GEO
2015-09-29 | GSE69428 | GEO
2014-04-11 | GSE52011 | GEO